Esperion Therapeutics to Present at Piper Sandler 37th Annual Healthcare Conference
Esperion Therapeutics Inc. will present at the Piper Sandler 37th Annual Healthcare Conference in New York on December 3, 2025. The company will discuss its progress in developing and commercializing FDA-approved, non-statin, oral medicines for cardiovascular disease patients. This presentation is part of their ongoing efforts as a commercial stage biopharmaceutical company.
Esperion Therapeutics Inc. will present at the Piper Sandler 37th Annual Healthcare Conference in New York on December 3, 2025, at 3:30 p.m. ET. The company will share updates on its progress as a commercial stage biopharmaceutical company focused on developing and commercializing FDA-approved, non-statin, oral medicines for patients at risk for cardiovascular disease. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Esperion Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9575435-en) on November 19, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)
